Holen Sie sich die Stockscreener-App
39.36
8.40%
3.05
Schlusskurs vom Vortag:
$36.31
Offen:
$36.38
24-Stunden-Volumen:
821.02K
Relative Volume:
1.66
Marktkapitalisierung:
$1.96B
Einnahmen:
$499.95M
Nettoeinkommen (Verlust:
$-36.36M
KGV:
-51.12
EPS:
-0.77
Netto-Cashflow:
$24.22M
1W Leistung:
+9.24%
1M Leistung:
+20.18%
6M Leistung:
+12.71%
1J Leistung:
+8.40%
1-Tages-Spanne:
$36.38
$39.73
1-Wochen-Bereich:
$34.88
$39.73
52-Wochen-Spanne:
$28.29
$43.11
Atricure Inc Stock (ATRC) Company Profile
Firmenname
Atricure Inc
Sektor
Telefon
513-755-4100
Adresse
7555 INNOVATION WAY, MASON, OH
Vergleichen Sie ATRC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ATRC
Atricure Inc
|
39.36 | 1.81B | 499.95M | -36.36M | 24.22M | -0.77 |
|
ISRG
Intuitive Surgical Inc
|
568.65 | 201.96B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
193.76 | 55.25B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
78.99 | 39.31B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
251.51 | 36.70B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
281.77 | 20.45B | 2.96B | 487.70M | 344.00M | 6.6758 |
Atricure Inc Stock (ATRC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-17 | Fortgesetzt | JP Morgan | Overweight |
| 2024-04-23 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2023-10-23 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-09-29 | Eingeleitet | UBS | Buy |
| 2021-08-05 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-12-18 | Bestätigt | Needham | Buy |
| 2020-11-06 | Bestätigt | Needham | Buy |
| 2020-04-07 | Eingeleitet | Oppenheimer | Outperform |
| 2020-02-06 | Eingeleitet | BTIG Research | Buy |
| 2020-01-24 | Bestätigt | Needham | Buy |
| 2019-08-13 | Herabstufung | Northland Capital | Outperform → Market Perform |
| 2019-04-12 | Eingeleitet | JP Morgan | Overweight |
| 2018-10-04 | Bestätigt | Needham | Buy |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-08-02 | Bestätigt | Stifel | Buy |
| 2018-06-18 | Bestätigt | Needham | Buy |
| 2018-04-27 | Bestätigt | Needham | Buy |
| 2018-01-16 | Bestätigt | Needham | Buy |
| 2017-11-02 | Bestätigt | Needham | Buy |
| 2017-07-28 | Bestätigt | Needham | Buy |
| 2017-05-30 | Fortgesetzt | Piper Jaffray | Overweight |
| 2016-06-30 | Fortgesetzt | JMP Securities | Mkt Outperform |
| 2015-10-28 | Bestätigt | Needham | Buy |
| 2015-10-06 | Bestätigt | Canaccord Genuity | Buy |
| 2015-10-06 | Bestätigt | Needham | Buy |
Alle ansehen
Atricure Inc Aktie (ATRC) Neueste Nachrichten
Will AtriCure Inc. stock deliver strong dividend growthPortfolio Profit Report & Expert Verified Stock Movement Alerts - Newser
Why analysts remain bullish on AtriCure Inc. stock2025 Trading Recap & Consistent Growth Stock Picks - Newser
Is AtriCure Stock a Buy or Sell After a Director Dumped 10,000 Shares? - sharewise.com
AtriCure’s Ongoing Study: Implications for Cardiac Treatment and Market Performance - MSN
Geode Capital Management LLC Purchases 14,577 Shares of AtriCure, Inc. $ATRC - MarketBeat
How supply chain issues affect AtriCure Inc. stockJuly 2025 Volume & Scalable Portfolio Growth Methods - BỘ NỘI VỤ
Atricure Executives Make Significant Stock Sales - TipRanks
Insider Sell: Justin Noznesky Sells 5,166 Shares of AtriCure Inc (ATRC) - GuruFocus
AtriCure Executives Engage in Stock Transactions - TradingView
Atricure Insider Sold Shares Worth $376,578, According to a Recent SEC Filing - MarketScreener
Dir Wehrwein Sells 10,000 ($376.6K) Of AtriCure Inc [ATRC] - TradingView
Officer Noznesky Sells 5,166 ($192.6K) Of AtriCure Inc [ATRC] - TradingView
ATRC Form 4: Director exercises $19.95 options, trims holdings - Stock Titan
[Form 4] AtriCure, Inc. Insider Trading Activity - Stock Titan
Precision Trading with Atricure Inc. (ATRC) Risk Zones - news.stocktradersdaily.com
Officer Noznesky Files To Sell 5,166 Of AtriCure Inc [ATRC] - TradingView
Atricure Director Makes a Significant Stock Sale! - TipRanks
AtriCure (NASDAQ:ATRC) Director Maggie Yuen Sells 3,000 Shares - MarketBeat
Wall Street Analysts Believe AtriCure (ATRC) Could Rally 36.3%: Here's is How to Trade - Finviz
Insider Sell: Maggie Yuen Sells 3,000 Shares of AtriCure Inc (AT - GuruFocus
AtriCure director Yuen sells $107k in shares By Investing.com - Investing.com Australia
AtriCure director Yuen sells $107k in shares - Investing.com
AtriCure Director Maggie Yuen Sells 3,000 Shares - TradingView
Dir Wehrwein Files To Sell 5,033 Of AtriCure Inc [ATRC] - TradingView
Dir Yuen Files To Sell 3,000 Of AtriCure Inc [ATRC] - TradingView
Is AtriCure (ATRC) Stock Outpacing Its Medical Peers This Year? - sharewise.com
Why AtriCure Inc. stock remains on buy lists2025 Growth vs Value & Safe Entry Momentum Stock Tips - newser.com
How AtriCure Inc. stock performs in rate cut cycles2025 EndofYear Setup & High Conviction Trade Alerts - newser.com
How sustainable is AtriCure Inc. stock dividend payoutTrade Performance Summary & Safe Swing Trade Setups - newser.com
Why AtriCure Inc. stock attracts high net worth investorsTrade Entry Report & Risk Managed Investment Strategies - newser.com
AtriCure Inc. stock trendline breakdownJuly 2025 Reactions & Real-Time Stock Movement Alerts - newser.com
Can AtriCure Inc. stock beat market expectations this quarterPortfolio Risk Summary & Long-Term Safe Investment Plans - newser.com
Why AtriCure Inc. stock remains undervaluedQuarterly Portfolio Review & Low Volatility Stock Suggestions - newser.com
Is AtriCure Inc. stock near bottom after decline2025 Price Action Summary & AI Driven Price Predictions - newser.com
Is AtriCure Inc. stock trading near support levelsGold Moves & High Accuracy Trade Alerts - newser.com
AtriCure Inc. stock trend forecastJuly 2025 Recap & Safe Investment Capital Preservation Plans - newser.com
AtriCure to Participate in the Piper Sandler 37th Annual Healthcare Conference - BioSpace
Exit strategy if you’re trapped in AtriCure Inc.Portfolio Risk Summary & Fast Gaining Stock Strategy Reports - newser.com
Finanzdaten der Atricure Inc-Aktie (ATRC)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.17%
0.89%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):